# Conexeu Sciences Inc.: filings

CNXU · Nasdaq · CIK 2066836 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/cnxu.md) · [Financials](/companies/cnxu/financials.md) · [Filings](/companies/cnxu/filings.md) · [Insiders](/companies/cnxu/insiders.md)

## Reports and events: 17 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (D 18, 3 15, 4 11, 424B3 7, SCHEDULE 13G 7, 8-K 6, S-1/A 6, 10-Q 2, C-U 2, D/A 2, 424B4 1, 4/A 1, 8-A12B 1, C 1, C/A 1, C-AR 1, CERT 1, EFFECT 1, S-1 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 16:30 ET | [8-K](/filings/0001062993-26-005569.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-26-005569 |
| 2026-10-20 | 16:30 ET | [8-K](/filings/0001062993-26-005431.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001062993-26-005431 |
| 2026-09-15 | 17:25 ET | [SCHEDULE 13D/A](/filings/0001062993-26-004967.md) | Ownership report, active investor, amended | 0001062993-26-004967 |
| 2026-09-14 | 16:30 ET | [10-Q](/filings/0001062993-26-004935.md) | Quarterly report, period 2026-07-31 | 0001062993-26-004935 |
| 2026-09-10 | 16:30 ET | [8-K](/filings/0001062993-26-004891.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001062993-26-004891 |
| 2026-08-18 | 06:04 ET | [SCHEDULE 13D](/filings/0001062993-26-004475.md) | Ownership report, active investor | 0001062993-26-004475 |
| 2026-07-07 | 17:12 ET | [8-K](/filings/0001062993-26-003545.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-26-003545 |
| 2026-06-15 | 16:30 ET | [10-Q](/filings/0001062993-26-003207.md) | Quarterly report, period 2026-04-30 | 0001062993-26-003207 |
| 2026-06-09 | 16:30 ET | [8-K](/filings/0001062993-26-003128.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001062993-26-003128 |
| 2026-05-15 | 16:22 ET | [8-K](/filings/0001062993-26-002703.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001062993-26-002703 |
| 2026-04-17 | 14:52 ET | [S-1/A](/filings/0001062993-26-002041.md) | Registration statement, amended | 0001062993-26-002041 |
| 2026-04-10 | 19:48 ET | [S-1/A](/filings/0001062993-26-001914.md) | Registration statement, amended | 0001062993-26-001914 |
| 2026-04-06 | 17:05 ET | [S-1/A](/filings/0001062993-26-001871.md) | Registration statement, amended | 0001062993-26-001871 |
| 2026-03-26 | 15:35 ET | [S-1/A](/filings/0001062993-26-001640.md) | Registration statement, amended | 0001062993-26-001640 |
| 2026-03-05 | 21:32 ET | [S-1/A](/filings/0001062993-26-001297.md) | Registration statement, amended | 0001062993-26-001297 |
| 2026-02-03 | 17:29 ET | [S-1/A](/filings/0001062993-26-000578.md) | Registration statement, amended | 0001062993-26-000578 |
| 2025-11-28 | 16:02 ET | [S-1](/filings/0001062993-25-017070.md) | Registration statement | 0001062993-25-017070 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:31 ET. No prices; not investment advice.